Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOCRYST PHARMACEUTICALS Financial Overview

  • Income Statement: BCRX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 56.56 M 71.24 M -14.68 M -25.95%
    Gross Profit 54.94 M 69.87 M -14.93 M -27.18%
    Net Income Before Extra Items/Preferred Div -24.73 M -29.06 M 4.32 M -17.48%
    Operating Income -27.16 M -32.28 M 5.12 M -18.83%
  • Cash Flow: BCRX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 666,639.00 66.77 M -66.10 M -9,915.76%
    Net Cash Flow - Investing -11.39 M 15.03 M -26.43 M 231.94%
    Net Cash Flow/Operating Activities -20.87 M -25.00 M 4.12 M -19.76%
  • Balance Sheet: BCRX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 84.69 M 142.72 M -58.03 M -68.51%
    Total Liabilities 38.27 M 77.81 M -39.55 M -103.35%
    Shareholders Equity 46.43 M 64.91 M -18.48 M -39.80%
  • Key Ratios / Statistics: BCRX

    • Valuation

      Price/Earnings (TTM) -2.11
      Price/Sales (TTM) 0.92
      Price/Book (MRQ) 4.94
      Price/Cash Flow (TTM) -37.70
    • Profitability

      Gross Margin 97.13
      Operating Margin -48.03
      Profit Margin -43.73
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.30
      Current Ratio (MRQ) 4.27
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -44.48
      Return on Assets (TTM) -23.18
      Return on Investments (TTM) -44.43